TY - JOUR
T1 - Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon-α-dependent apoptosis
AU - Ato, Manabu
AU - Takahashi, Yoshimasa
AU - Fujii, Hideki
AU - Hashimoto, Shu ichi
AU - Kaji, Tomohiro
AU - Itamura, Shigeyuki
AU - Horiuchi, Yoshinobu
AU - Arakawa, Yoshichika
AU - Tashiro, Masato
AU - Takemori, Toshitada
N1 - Funding Information:
We thank for Dr. Shizuo Akira for providing us MyD-88 KO and TLR7 KO mice, Dr. Shinsuke Taki (Shinshu University), Dr. Noriko Sorimachi (National Center for Global Health and Medicine), and Dr. Kiichi Yamamoto (Tokyo Medical and Dental University) for providing us reagents and techniques. We are grateful to Ms. Yoko Nakamura for technical help. This work is supported by Grants from the Ministry of Health, Labor, and Welfare of Japan .
PY - 2013/4/19
Y1 - 2013/4/19
N2 - Infection with single strand RNA (ssRNA) viruses, such as influenza A virus, is known to induce protective acquired immune responses, including the production of neutralizing antibodies. Vaccination also causes a reduction in the number of peripheral blood leukocytes (PBL) shortly after inoculation, a result which may have undesirable adverse effects. The cellular mechanisms for this response have not been elucidated so far. Here we report that formalin-inactivated influenza A whole virus vaccine (whole virion) induces a significant decrease in PBL in mice 5-16. h after administration, whereas an ether-split vaccine (HA split) made from the same influenza virus strain does not induce a similar loss of PBL. Concordant with this reduction in the number of PBL, a rapidly induced and massive production of interferon (IFN)-α is observed when mice are injected with whole virion, but not with HA split vaccines. The role of Toll-like receptors (TLR), which are involved in signal transduction of influenza virus, and the subsequent induction of IFNα were confirmed using mice lacking TLR7, MyD-88, or IFNα/β receptor. We further demonstrated that the observed PBL loss is caused by apoptosis in an IFNα-dependent manner, and not by leukocyte redistribution due to chemokine signaling failure. These findings indicate that RNA-encapsulated whole virion vaccines can rapidly induce a loss of leukocytes from peripheral blood by apoptosis, which may modulate the subsequent immune response.
AB - Infection with single strand RNA (ssRNA) viruses, such as influenza A virus, is known to induce protective acquired immune responses, including the production of neutralizing antibodies. Vaccination also causes a reduction in the number of peripheral blood leukocytes (PBL) shortly after inoculation, a result which may have undesirable adverse effects. The cellular mechanisms for this response have not been elucidated so far. Here we report that formalin-inactivated influenza A whole virus vaccine (whole virion) induces a significant decrease in PBL in mice 5-16. h after administration, whereas an ether-split vaccine (HA split) made from the same influenza virus strain does not induce a similar loss of PBL. Concordant with this reduction in the number of PBL, a rapidly induced and massive production of interferon (IFN)-α is observed when mice are injected with whole virion, but not with HA split vaccines. The role of Toll-like receptors (TLR), which are involved in signal transduction of influenza virus, and the subsequent induction of IFNα were confirmed using mice lacking TLR7, MyD-88, or IFNα/β receptor. We further demonstrated that the observed PBL loss is caused by apoptosis in an IFNα-dependent manner, and not by leukocyte redistribution due to chemokine signaling failure. These findings indicate that RNA-encapsulated whole virion vaccines can rapidly induce a loss of leukocytes from peripheral blood by apoptosis, which may modulate the subsequent immune response.
KW - Apoptosis
KW - Inactivated influenza vaccine
KW - Innate immunity
KW - Leukocytopenia
KW - Type-I interferons
UR - http://www.scopus.com/inward/record.url?scp=84875830144&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875830144&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2013.02.016
DO - 10.1016/j.vaccine.2013.02.016
M3 - Article
C2 - 23434386
AN - SCOPUS:84875830144
SN - 0264-410X
VL - 31
SP - 2184
EP - 2190
JO - Vaccine
JF - Vaccine
IS - 17
ER -